GE inks FFDM sales deal with Fusion

AuntMinnie.com staff writers
May 23, 2006

GE Healthcare of Chalfont St. Giles, U.K., has signed a deal to outsource sales of its Senographe Essential full-field digital mammography (FFDM) system to Fusion Sales Partners, a Baltimore-based sales outsourcing firm.

GE has named Fusion as its exclusive sales partner for Senographe Essential, creating an alternative sales channel for the product, which recently received U.S. Food and Drug Administration 510(k) clearance. Fusion has provided sales support for other GE products in the past.

By AuntMinnie.com staff writers
May 24, 2006

Related Reading

GE, St. Jude Medical partner on cardiac imaging, May 16, 2006

GE debuts compact US units, May 15, 2006

SonoSite disputes GE marketing claims, May 15, 2006

GE gets FDA nod for Voluson I, May 11, 2006

GE partners with Mayo on 3T MRI, May 9, 2006

Copyright © 2006 AuntMinnie.com

Latest in Breast
Mri Breast Cancer
Women with BRCA1/2 germline mutations are often denied breast MRI
January 3, 2025
Abnormal mammogram (left) compared with normal mammogram. Image courtesy of the RSNA.
Study shows women will pay for AI breast cancer screening exam
December 5, 2024
Sectra Rsna 2019 400
Sectra inks 5-year deal with MaineGeneral Health
October 15, 2024
Breast Cancer
New theranostics pairing tested in breast cancer patients
July 31, 2024
Related Stories
187x200 Am Logo
Companies
AuntMinnie.com
Ge Health Care Logo (jan 2023)
Vendors
GE HealthCare
2006 03 30 13 45 47 706
Breast
AuntMinnie's IMV MarketStat #40: Lead time for scheduling a screening mammography appointment
2006 03 15 12 39 41 706
Breast
Swedish start-up XCounter pursues 3D mammography
More in Breast
Women with BRCA1/2 germline mutations are often denied breast MRI
By Kate Madden Yee
Women with BRCA1/2 germline mutations are often denied breast MRI -- despite the fact that the exam is recommended for this population.
January 3, 2025
Mri Breast Cancer
Study shows women will pay for AI breast cancer screening exam
By Liz Carey
Some clinical practices have elected to offer enhanced workflows enabled by AI, at an additional cost.
December 5, 2024
Abnormal mammogram (left) compared with normal mammogram. Image courtesy of the RSNA.
Sectra inks 5-year deal with MaineGeneral Health
By AuntMinnie.com staff writers
Sectra has secured a five-year agreement with MaineGeneral Health to use Sectra One Cloud and its modules for radiology and breast imaging.
October 15, 2024
Sectra Rsna 2019 400
New theranostics pairing tested in breast cancer patients
By Kate Madden Yee
A new theranostics pairing of molecular imaging and radioligand therapy shows promise as a treatment option for patients with metastatic breast cancer, researchers have found.
July 31, 2024
Breast Cancer
Black women less likely to undergo preoperative breast MRI
By Kate Madden Yee
Black women diagnosed with breast cancer are less likely than their white counterparts to undergo preoperative MRI, researchers report.
July 10, 2024
Mri Breast Cancer
Breakthroughs in cancer breast screening technologies
By Erik Anderson
Erik Anderson of women's imaging vendor Hologic discusses the impact of recent technological advances for detecting and diagnosing breast cancer.
July 5, 2024
Erik Anderson thumb
Uniting for health equity: Addressing breast cancer disparities
By Dana Brown
Juneteenth marks the emancipation of enslaved people in the U.S. and is a time to reflect on both the progress toward equality and the disparities that remain.
June 19, 2024
Black Women Hands Mammography
Critics slam Canadian breast screening guidelines
By Amerigo Allegretto
Breast imaging advocates and political bodies are criticizing updated guidelines on breast cancer screening by the CTFPHC.
May 31, 2024
Canada Montreal Skyline 400
FES-PET could save $142M in breast cancer costs
By Will Morton
Adding F-18 fluroestradiol (FES)-PET/CT imaging to standard of care tests in women with suspected estrogen receptor-positive breast cancer could save millions.
May 20, 2024
Breast Mol
New guidance issued on PET/CT imaging in breast cancer
By Will Morton
The world’s top nuclear medicine societies have issued international guidelines on the role of PET/CT in patients with invasive ductal carcinoma.
May 17, 2024
Breast Mol
ARRS: Dartmouth poster wins for CVD risk prediction potential using mammograms
By Liz Carey
A poster on cardiovascular disease (CVD) risk prediction using fat-enlarged axillary nodes on mammograms won a prestigious award at ARRS 2024.
May 6, 2024
Award-winning research: Screening mammograms showed variable lymph node morphology due to ectopic fat deposition in women with obesity. Image A (above) shows normal axillary lymph nodes measuring < 1.5 cm in 63-year-old woman with a body mass index (BM) = 43.2. Image B shows a possible fat-enlarged axillary node with large fatty hilum measuring 4.2 cm in a 52-year-old woman with a BMI = 45.8. Photo courtesy of American Roentgen Ray Society.
DBT + CEM boosts cancer detection in women with history of the disease
By Kate Madden Yee
Adding contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) increases early breast cancer detection in women with a history of the disease.
April 30, 2024
Breast Cancer3
Page 1 of 570
Next Page